[{"from": "human", "value": "Provide a description of this molecule. [C][C][=C][Branch1][S][N][=C][Branch1][Ring2][O][Ring1][Branch1][C][=C][C][=C][C][=C][Ring1][=Branch1][C][C][O][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][N][Branch1][#Branch1][C][C][=Branch1][C][=O][O][C][=Branch1][C][=O][O][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C]"}, {"from": "gpt", "value": "The molecule is a dual peroxisome proliferator-activated receptor (PPAR) agonist, with hypoglycemic activity. Muraglitazar causes an increase in HDL-C levels, and a decrease in total cholesterol, apolipoprotein B, triglycerides and HbA1c. This agent is associated with an increased risk of adverse cardiovascular events and heart failure."}]